BioSpace News Archive

Bioburden testing is a course of estimating reasonable microorganisms on clinical gadgets, unrefined substance, or bundle.

Immunoassay is a technique for distinguishing or estimating a particular sort of protein. The market utilizes various kinds of immunizer antigen responses to distinguish the organic substance in the liquid and blood.

Albany NY, United States: Stem cells are found in all human beings, from the initial stages of human growth to the end of life.

Albany NY, United States: Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation.

Santhera Pharmaceuticals announces the appointment ofShabir Hasham, MD,as Chief Medical Officer and a member of Santhera’s Executive Management team, effective May 1, 2022.

Takeda Pharmaceutical Company Limited provided an update on the status and announced the completion of the acquisition of its own shares, which has been carried out pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act of Japan, based on the resolution of the Board of Directors’ meeting held on October 28, 2021. Details of the acquisition of shares is below.

AlzeCure Pharma AB has completed a rights issue of shares that closed on March 22, 2022.

Avacta Group plc is pleased to announce that a milestone equity payment has been triggered resulting in an increase in Avacta’s shareholding in AffyXell Therapeutics, a joint venture between Avacta and Daewoong Pharmaceutical in South Korea.

Cerevel Therapeutics announced it will report first quarter 2022 financial results on Tuesday, May 10, 2022, before the U.S. financial markets open.

CollPlant today announced that Dr. Jasmine Seror, CollPlant’s Head of Aesthetic Medicine and Exploratory Products, will deliver a presentation at the Aesthetics Innovation Summit 2022, to be held in San Diego, California, on Wednesday, April 20, 2022.